Florida, February 26, 2018:

    Transfection Reagents and Equipment Market 2018

    The Global Transfection Reagents and Equipment Market is expected to exceed more than US$ 1.0 Billion by 2022 at a CAGR of 7% in the given forecast period.

    The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market.

    Key players profiled in the report include

    Promega Corporation

    Hoffmann-La Roche Ltd.

    QIAGEN N.V.

    Polyplus-transfection SA  

    Mirus Bio LLC (U.S.), and MaxCyte Inc.

    Bio-Rad Laboratories

    Thermo Fisher Scientific Inc.

    Lonza Group

    Sigma-Aldrich Corporation

    Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

    Browse full Report: https://www.marketresearchengine.com/transfection-reagents-and-equipment-market

    The Global Transfection Reagents and Equipment Market has been segmented as below:

    By Product Analysis:

    • Reagents
    • Instruments

    By Method Analysis:

    • Biochemical
    • Calcium Phosphate
    • Lipofection
    • DEAE-dextran
    • Dendrimers
    • Physical
    • Electroporation
    • Nucleofection
    • Others (Genegun, Sonoporation, Magnetofection, and Optoinjection)
    • Viral

    By Application Analysis:

    • Biomedical Research
    • Gene Expression Studies
    • Cancer Research
    • Transgenic Model
    • Protein Production
    • Therapeutic Deli very

    By End User Analysis:

    • Academic & Research Institutes
    • Pharmaceutical & Biotechnology Companies

    By Regional Analysis:

    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World

    This report provides:

    1) An overview of the global market for Nasal Spray Market and related technologies.

    2) Analyses of global market trends, with data from 2014, estimates for 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022.

    3) Identifications of new market opportunities and targeted promotional plans for Transfection Reagents and Equipment Market

    4) Discussion of research and development, and the demand for new products and new applications.
    5) Comprehensive company profiles of major players in the industry.

    Buy Report from here: https://www.marketresearchengine.com/transfection-reagents-and-equipment-market

    Table of Contents:

    1 INTRODUCTION
    1.1    KEY TAKE AWAYS
    1.2    REPORT DESCRIPTION
    1.3    MARKETS COVERED
    1.4    STAKEHOLDERS
    1.5    RESEARCH METHODOLOGY
    1.5.1    MARKET SIZE
    1.5.2    MARKET SHARE
    1.5.3    KEY DATA POINTS FROM SECONDARY SOURCES
    1.5.4    KEY DATA POINTS FROM PRIMARY SOURCES

    2 Research Methodology
    2.1 Research Methodology Steps
    2.2 Secondary and Primary Research Methodology
    2.2.1 Secondary Research
    2.2.1.1 Key Data From Secondary Sources
    2.2.2 Primary Research
    2.2.2.1 Key Data From Primary Sources
    2.2.2.2 Key Insights From Primary Sources
    2.2.2.3 Key Industry Insights
    2.3 Market Size Estimation Methodology
    2.3.1 Market Forecast Methodology
    2.4 Market Data Validation and Triangulation
    2.5 Assumptions

    3 Executive Summary
    3.1 Introduction
    3.2 Conclusion

    4 Premium Insights
    4.1 Global Transfection Technologies Market
    4.2 Transfection Technologies Market, By Application & Region
    4.3 Geographic Snapshot: Transfection Technologies Market
    4.4 Transfection Technologies Market, By Product (2016 vs 2021)
    4.5 Transfection Technologies Market, By End User, 2016 vs 2021 (USD Million)

    5 Market Overview
    5.1 Introduction
    5.2 Market Dynamics
    5.2.1 Drivers
    5.2.1.1 Technological Advancements in Transfection Technology
    5.2.1.1.1 Crispr-Cas9
    5.2.1.1.2 Car-T
    5.2.1.1.3 Three Dimension (3D) Transfection Technology
    5.2.1.2 Global Alliances Among Leading Research Institutes to Trigger Drug Discovery
    5.2.1.3 Increase in R&D Spending and Research Activities By Pharmaceutical and Biotech Companies
    5.2.1.4 Growing Research Activities in Cell Science
    5.2.1.5 Increase in Demand for Synthetic Genes
    5.2.1.6 Rising Incidence of Cancer Worldwide
    5.2.2 Restraints
    5.2.2.1 Selective Effectiveness of Transfection Reagents
    5.2.2.2 Home Brew Reagents Restrict Sale of Commercial Kits
    5.2.2.3 High Cost of Transfection Reagents
    5.2.3 Opportunities
    5.2.3.1 Large-Scale Transfections
    5.2.3.2 High-Growth Opportunities in Asian Market
    5.2.3.2.1 India
    5.2.3.2.2 China
    5.2.4 Challenges
    5.2.4.1 Transfection in Hard-To-Transfect Cells
    5.2.4.2 Cytotoxicity in Transfection – A Major Concern

    6 Transfection Technologies Market, By Product
    6.1 Introduction
    6.2 Reagents
    6.3 Equipment

    7 Transfection Technologies Market, By Method
    7.1 Introduction
    7.2 Biochemical Methods
    7.2.1 Lipofection
    7.2.1.1 Advantages
    7.2.1.2 Disadvantages
    7.2.2 Calcium Phosphate
    7.2.2.1 Advantages
    7.2.2.2 Disadvantages
    7.2.3 Deae-Dextran
    7.2.3.1 Advantages
    7.2.3.2 Disadvantages
    7.2.4 Dendrimers
    7.2.4.1 Advantages
    7.2.4.2 Disadvantages
    7.3 Physical
    7.3.1 Electroporation
    7.3.1.1 Advantages
    7.3.1.2 Disadvantages
    7.3.2 Nucleofection
    7.3.2.1 Advantages
    7.3.2.2 Disadvantages
    7.3.3 Other Methods
    7.3.3.1 Sonoporation
    7.3.3.2 Genegun
    7.3.3.2.1 Advantages
    7.3.3.2.2 Disadvantages
    7.3.3.3 Magnetofection
    7.3.3.3.1 Advantages
    7.3.3.3.2 Disadvantages
    7.3.3.4 Optoinjection
    7.3.3.4.1 Advantages
    7.3.3.4.2 Disadvantages
    7.4 Viral Methods
    7.4.1 Adenoviruses
    7.4.2 Retroviruses
    7.4.3 Adenoassociated Viruses (AAV)

    8 Transfection Technologies Market, By Application
    8.1 Introduction
    8.2 Biomedical Research
    8.2.1 Gene Expression Studies
    8.2.2 Cancer Research
    8.2.3 Transgenic Models
    8.3 Protein Production
    8.4 Therapeutic Delivery

    9 Transfection Technologies Market, By End User
    9.1 Introduction
    9.2 Academics & Research Institutes
    9.3 Pharmaceutical & Biotechnology Companies

    10 Transfection Technologies Market, By Region
    10.1 Introduction
    10.2 North America
    10.2.1 U.S.
    10.2.1.1 Increase in Bio-Based Drug Research
    10.2.1.2 Growing Demand for Protein-Based Therapeutics Triggers the Growth of U.S. Market
    10.2.1.3 Increasing Funding for Biotechnology and for Development of Protein-Based Biologics
    10.2.1.4 Conferences/Meetings/Symposiums/Workshops
    10.2.2 Canada
    10.2.2.1 Government Support for Development of Protein Drugs is Expected to Drive the Market for Transfection Technologies
    10.2.2.2 Increasing Investments By the Canadian Government on Regenerative Medicine to Drive Market Growth
    10.2.2.3 Increasing Funding for Genome Engineering in Canada Likely to Boost Transfection Technologies Market
    10.3 Europe
    10.3.1 Germany
    10.3.1.1 Growing Biotech Industry and Research Funding in Germany
    10.3.1.2 Collaboration Among Bio-Pharmaceutical and Biotechnology Companies for the Development of New Vaccines is Likely to Drive the Market Growth
    10.3.1.3 Conferences and Meetings/Workshops in Germany
    10.3.1.4 Availability of Funding for Life Science Research in Germany
    10.3.2 U.K.
    10.3.2.1 10,000 Genome Project Initiative in U.K.
    10.3.2.2 Initiative to Increase R&D Investments in U.K.
    10.3.3 Rest of Europe
    10.3.3.1 Growing Biotechnology and Pharma Industry in Italy
    10.3.3.2 Focus on Research in Spain
    10.3.3.3 Investments and Funding for Life Sciences to Drive the Transfection Technologies Market
    10.3.3.4 Growing Research Investments in Sweden & Denmark
    10.4 Asia-Pacific
    10.4.1 Japan
    10.4.1.1 Rise in Biomedical Research in Japan
    10.4.2 China
    10.4.2.1 Chinese Government Initiatives for Life Sciences R&D Likely to Boost the Market
    10.4.2.2 Industry Initiative to Boost Transfection Technology Market in China
    10.4.3 India
    10.4.3.1 Booming Pharmaceutical and Biotechnology Industries
    10.4.3.2 Development of Bio-Clusters in India
    10.4.4 Rest of Asia-Pacific
    10.4.4.1 Federal Collaborations in Australia
    10.4.4.2 Funding for Research on Proteomics and Genomics in Australia
    10.4.4.3 Rising Pharmaceutical and Biotechnology R&D Activities in South Korea
    10.4.4.4 Government Support for Strong Academic and Commercial R&D Activities in Taiwan
    10.4.4.5 Genome Asia 100k Initative
    10.5 Rest of the Word (RoW)
    10.5.1 Latin America
    10.5.1.1 Increasing Investment in Brazil and Mexico
    10.5.1.2 Brazil: Investment in Research and Innovation Centers and Conferences & Workshops
    10.5.2 Middle East & Africa
    10.5.2.1 Increasing Focus of Major Pharmaceutical, Biopharmaceutical, and Biotechnology Firms in Saudi Arabia and the United Arab Emirates (UAE) and African Regions
    10.5.2.2 Genetic Testing and Genomic Analysis in the Middle East

    11 Competitive Landscape
    11.1 Overview
    11.2 Market Share Analysis
    11.2.1 Introduction
    11.2.2 Thermo Fisher Scientific Inc.
    11.2.3 Promega Corporation
    11.2.4 F. Hoffmann-La Roche Ltd
    11.2.5 Qiagen N.V.
    11.3 Competitive Situation and Trends
    11.4 Agreements, Collaborations and Partnerships
    11.5 New Product Launches
    11.6 Expansions
    11.7 Acquisitions
    11.8 Other Strategies

    12 Company Profiles
    12.1 Thermo Fisher Scientific Inc. (Life Technologies)
    12.2 Promega Corporation
    12.3 Qiagen N.V.
    12.4 F. Hoffmann-La Roche Ltd
    12.5 Bio–Rad Laboratories, Inc.
    12.6 Maxcyte, Inc.
    12.7 Lonza Group Ltd.
    12.8 Merck KGaA
    12.9 Polyplus-Transfection Sa (Subsidary of Archimed)
    12.10 Mirus Bio LLC.

    Media Contact

    Company Name: Market Research Engine

    Contact Person: John Bay

    Email: john@marketresearchengine.com

    Phone: +1-855-984-1862

    Country: United States

    Website: https://www.marketresearchengine.com/

    Source: http://www.financeswire.com/transfection-reagents-and-equipment-market-2018-industry-analysis-growth-and-forecast-to-2022